Audit Services

Mock FDA & EMA Inspection Readiness

A full dress-rehearsal inspection that mirrors a real FDA or EMA visit — so your team and your documentation are ready before the agency arrives.

An inspection is not the time to discover a gap. A mock inspection recreates the scope and pressure of a real FDA (BIMO) or EMA GCP inspection — document review, system walkthroughs and staff interviews — then hands you a prioritized list of what to fix while you still have time.

I tailor the mock inspection to the type expected (sponsor, site or CRO; pre-approval or routine) and to the study's risk profile.

What the audit covers

  • TMF and essential-document review
  • Source-document and data-integrity review
  • Systems and 21 CFR Part 11 walkthrough
  • Staff interviews and inspection-behavior coaching
  • Inspection-readiness narrative / storyboard review
  • Front-room / back-room process dry run

What you receive

  • Mock-inspection report with risk-ranked findings
  • Prioritized, time-boxed CAPA / readiness plan
  • Readiness briefing for leadership and staff

Why it matters

Teams that rehearse inspect better. A mock inspection reduces surprises, builds staff confidence, and turns a high-stakes event into a managed one.

Standards & frameworks

FDA BIMO Program ICH E6 GCP 21 CFR Part 312 / 812 EMA GCP 21 CFR Part 11

Frequently asked questions

What is a mock FDA inspection?

A mock FDA inspection is a simulated regulatory inspection conducted by an independent auditor that mirrors the FDA's approach — reviewing documents and systems and interviewing staff — to identify and fix gaps before the real inspection.

How far before an inspection should we run a mock?

Ideally several weeks to a few months ahead, so there is time to remediate findings and verify CAPAs. A focused readiness check closer to the date can confirm the fixes held.

Ready to make your trial inspection-ready?

Free initial consultation to scope your audit needs — usually a reply within one business day.